Humana (NYSE: HUM ) reported Q2 EPS of $1.67, $0.04 better than the analyst estimate of $1.63. Revenue for the quarter came in at $13.73 billion versus the consensus estimate of $13.81 billion.

The company expects EPS for the quarter ending September 30, 2015 to be approximately $2.15. The company continues to project EPS for the year ending December 31, 2015 (FY 2015) of approximately $9.28. The company reaffirms its estimate for Adjusted EPS for FY 2015 of approximately $7.75 as noted below:

Diluted earnings per common share FY 2015

GAAP $ 9.28

2Q 2015 gain related to sale of Concentra (1.18 )

1Q 2015 tax benefit related to then-pending sale of Concentra (0.35 )

Adjusted (non-GAAP) $ 7.75

For earnings history and earnings-related data on Humana (HUM ) click here.